Status:
COMPLETED
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Ambry Genetics
Conditions:
Breast Cancer
Ovarian Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.
Detailed Description
This prospective, randomized controlled trial will evaluate the effect of two pre-test education methods on the level of participation in genetic testing for hereditary cancer risk. A prospective stud...
Eligibility Criteria
Inclusion
- Potentially eligible participants will be identified via medical record screening and/or in accordance with their clinical visit. A HIPAA waiver of authorization will be obtained by the enrolling Institution as needed to have access to the subject's medical record information for screening of eligibility.
- A member of the study team will approach the potentially eligible participant in clinic and discuss the trial. Potentially eligible participants may choose to discuss participation further with their physician at their appointment
- Age ≥ 18 years
- Breast, ovarian, pancreatic, or metastatic prostate cancer
- No prior cancer genetic testing
- Ability to understand and the willingness to sign an informed consent document
Exclusion
- Pregnant
- Prisoners
- Inability to understand English as a spoken language in a healthcare context
- Known hematologic malignancy (e.g. CLL)
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT04330716
Start Date
December 1 2020
End Date
December 31 2023
Last Update
January 19 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
2
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Brighton, Massachusetts, United States, 02135
3
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, United States, 01757
4
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital
Weymouth, Massachusetts, United States, 02190